Related Experiment Video

Updated: Jun 18, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

[Macrovascular diabetic complications: clinical characteristics, diagnosis and management]

Cristina Triches1, Beatriz D'Agord Schaan, Jorge Luiz Gross

  • 1Programa de Pós-graduação em Ciências Médicas: Endocrinologia e Metabologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.

Arquivos Brasileiros De Endocrinologia E Metabologia
|November 7, 2009
PubMed

Insights

Diabetes mellitus (DM) significantly increases cardiovascular disease risk and mortality. Intensive treatment and strict risk factor control are crucial for improving outcomes in patients with diabetic macrovascular complications.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Context:

  • Diabetes mellitus (DM) is a major independent risk factor for cardiovascular diseases (CVDs), including coronary heart disease, stroke, peripheral arterial disease, and heart failure.
  • Patients with DM and established CVD exhibit poorer prognoses, lower survival rates, and increased recurrence risk compared to non-diabetic individuals.
  • Despite advancements in diagnosis and therapy, the absolute mortality risk in diabetic patients with CVD remains double that of non-diabetic patients.

Purpose:

  • To outline the key clinical characteristics of patients suffering from diabetic macrovascular disease.
  • To present a practical approach for the screening, diagnosis, and management of diabetic macrovascular complications.
  • To emphasize the importance of intensive treatment strategies for cardiovascular risk reduction in diabetic patients.

Summary:

  • This study details the clinical profiles of individuals with diabetic macrovascular disease.
  • It provides a guide for identifying, diagnosing, and treating these patients.
  • The focus is on aggressive management of cardiovascular risk factors.

Impact:

  • Highlights the critical need for proactive cardiovascular risk management in diabetes care.
  • Aims to improve clinical decision-making for better patient outcomes.
  • Underscores the persistent high mortality risk associated with diabetic macrovascular disease, necessitating optimized therapeutic interventions.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...